The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck Serono

Final overall survival (OS) analysis of first-line (1L) FOLFOX-4 ± cetuximab (cet) in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) in the phase 3 TAILOR trial.
 
Shukui Qin
No Relationships to Disclose
 
Weijian Guo
No Relationships to Disclose
 
Jian-Ming Xu
No Relationships to Disclose
 
Qi Li
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Tian Shu Liu
No Relationships to Disclose
 
Jiongjie Chen
Employment - Merck Serono
 
Wen-Feng Chen
No Relationships to Disclose
 
Jin Li
Honoraria - Jiangsu Hengrui Medicine; Merck; Roche
Consulting or Advisory Role - Luye Pharma; QiLu Pharmaceutical
Speakers' Bureau - Lilly